4.6 Review

Novel Approaches to Prevent Epileptogenesis After Traumatic Brain Injury

期刊

NEUROTHERAPEUTICS
卷 18, 期 3, 页码 1582-1601

出版社

SPRINGER
DOI: 10.1007/s13311-021-01119-1

关键词

Anti-epileptogenesis; Biomarker; Epileptogenesis; Post-traumatic epilepsy; Treatment

资金

  1. Medical Research Council of the Academy of Finland [272249, 273909, 2285733-9]
  2. European Union's Seventh Framework Programme [602102]
  3. National Institute of Neurological Disorders and Stroke (NINDS) [U54 NS100064, R33 NS096948, R01 NS113499, R01 NS100706]
  4. Department of Defense [W81XWH-18-1-0669, W81XWH-17-1-0531]

向作者/读者索取更多资源

Traumatic brain injury (TBI) can lead to post-traumatic epilepsy (PTE) which often resists standard anti-seizure drugs. Novel treatment strategies are needed to prevent PTE after TBI, as there are no successful approaches currently available. TBI presents a unique opportunity for intervention to prevent epileptogenesis, with potential for exciting new advances in the field.
Traumatic brain injury (TBI) is defined as an alteration in brain function or other evidence of brain pathology caused by an external force. When epilepsy develops following TBI, it is known as post-traumatic epilepsy (PTE). PTE occurs in a subset of patients suffering from different types and severities of TBI, occurs more commonly following severe injury, and greatly impacts the quality of life for patients recovering from TBI. Similar to other types of epilepsy, PTE is often refractory to drug treatment with standard anti-seizure drugs. No therapeutic approaches have proven successful in the clinic to prevent the development of PTE. Therefore, novel treatment strategies are needed to stop the development of PTE and improve the quality of life for patients after TBI. Interestingly, TBI represents an excellent clinical opportunity for intervention to prevent epileptogenesis as typically the time of initiation of epileptogenesis (i.e., TBI) is known, the population of at-risk patients is large, and animal models for preclinical studies of mechanisms and treatment targets are available. If properly identified and treated, there is a true opportunity to prevent epileptogenesis after TBI and stop seizures from ever happening. With that goal in mind, here we review previous attempts to prevent PTE both in animal studies and in humans, we examine how biomarkers could enable better-targeted therapeutics, and we discuss how genetic variation may predispose individuals to PTE. Finally, we highlight exciting new advances in the field that suggest that there may be novel approaches to prevent PTE that should be considered for further clinical development.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据